维普期刊资源整合服务平台（V6.5）

311篇 您的检索式：作者名="Laterre PF"

选中清除导出查看参考文献查看引证文献引用追踪共16页首页上一页第1页下一页末页 /16 跳转

	题名	作者	年代	出处	被引量
1	Efficacy and safety of recombinant human activaled protein C for severe sepsis 显示文摘	Bernard GR Vincent JL Laterre PF	2001	N Engl J Med2001，344，10：	1
2	CURB-65, PSI, and APACHE Ⅱ to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS 显示文摘	Richards G Levy H Laterre PF	2011	J Intensive Care Med2011，26，1：	1
3	Drotrecoginalfa (acti- vated) for adults with severe sepsis and a low risk of death 显示文摘	Abraham E Laterre PF Garg R	2010	New Engl J Med2010，353，13：	1
4	A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection显示文摘	Vincent JL Laterre PF Cohen J	2005	Shock2005，23，5：	1
5	Efficacy and safety of recombinant human activated protein C for severe sepsis 显示文摘	Bernm'd GR Vincent JL Laterre PF	2001	N Engl J Med2001，344，10：	1
6	Efficacy and safety of recombinant human activated protein C for severe sepsis显示文摘	Bernard GR Vincent JL Laterre PF	2001	N Engl J Med2001，344，10：	1
7	Electrocardiographic changes after head trauma 显示文摘	Wittebole X Hantson P Laterre PF	2005	J Electrocardiol2005，1，：	1
8	A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia 显示文摘	Laterre PF Opal SM Abraham E	2009	Crit Care2009，13，2：	1
9	Efficacy and safety of recombinant human activated protein C for severe sepsis 显示文摘	Bernard GR Vincent JL Laterre PF	2001	NEJM2001，344，10：	1
10	Efficacy and safety of recombinant human activated protein C for severe sepsis显示文摘	Bernard GR Vincent JL Laterre PF	2001	N Engl J Med2001，344，：	1
11	Compartmentalization of the inflammatory response during acute pancreatitis: correlation with local and systemic complications 显示文摘	Dugernier TL Laterre PF Wittebole X	2003	Am J Respir Crit Care Med2003，168，2：	1
12	Efficacy and safety of recombinant human activated protein Cfor severe sepsis 显示文摘	Gordon R Vincent JL Laterre PF	2001	New Eng J Med2001，344，10：	1
13	Efficacy and safety of recombinant human activated protein C for severe sepsis显示文摘	Bernard GR Vincent JL Laterre PF	2001	New Engl J Med2001，344，10：	1
14	Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia: a randomized trial显示文摘	Wunderink RG Laterre PF Francois B	2011	Am J Respir Crit Care Med2011，183，11：	1
15	Toll-like receptor 4 modulation as a strategy to treat sepsis 显示文摘	Wittebole X Castanares-Zapatero D Laterre PF	2010	Mediators Inflamm2010，2010，56：	1
16	Adult liver transplantation:UCL experience显示文摘	Lerut J Laterre PF Roggen F	1999	Acta Gastroenlerol Belg1999，62，3：	1
17	The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): role, methodology,and results显示文摘	Dhainaut JF Laterre PF LaRosa SP	2003	Crit Care Med2003，31，9：	1
18	Systemic and local high mobility group box 1 concentrations during severe infection显示文摘	van Zoelen MA Laterre PF van Veen SQ	2007	Crit Care Med2007，35，12：	1
19	Efficacy and safety of recombinant human activated protein C for severe sepsis 显示文摘	Bernard GR Vincent JL Laterre PF	2001	N Engl J Med2001，344，10：	1
20	Efficacy and safety of recombinant human activated protein C for severe sepsis 显示文摘	Bernard GR Vincent JL Laterre PF	2001	N Engl J Med2001，344，10：	1

返回顶部每页显示：

共16页首页上一页第1页下一页末页 /16 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示